Revolutionary ‘Circulatronics’ Offer Hope for Non-Surgical Brain Implants
MIT researchers have unveiled a groundbreaking technology that could deliver therapeutic brain implants via a simple injection, potentially revolutionizing the treatment of neurological disorders and eliminating the need for invasive surgery.
What if clinicians could place tiny electronic chips in the brain to electrically stimulate precise targets,through a simple injection in the arm? This once-distant prospect is now significantly closer to reality,thanks to a major advancement by researchers at the Massachusetts Institute of technology (MIT). They have developed microscopic, wireless bioelectronics capable of traveling through the circulatory system and autonomously self-implanting in targeted brain regions to provide focused treatment.
in a study published November 5, 2025, in Nature Biotechnology, the team demonstrated that these minuscule implants, after injection, can identify and navigate to a specific brain region in mice without human guidance. Once in place, they can be wirelessly powered to deliver electrical stimulation – a process known as neuromodulation – which has shown promise in treating conditions like brain tumors, Alzheimer’s disease, and multiple sclerosis.
A key innovation lies in the implants’ biocompatibility.By integrating the electronic devices with living cells before injection, the researchers have overcome a major hurdle: preventing the body’s immune system from attacking the foreign objects. This integration also allows the devices to safely cross the blood-brain barrier, a protective layer that typically restricts access to the brain. “The living cells camouflage the electronics so that they aren’t attacked by the body’s immune system and they can travel seamlessly through the bloodstream,” explained a senior researcher. “This also enables them to squeeze through the intact blood-brain barrier without the need to invasively open it.”
The technology, dubbed “circulatronics,” was successfully used in the study to target brain inflammation, a common factor in many neurological diseases. The implants achieved high precision, delivering localized neuromodulation deep within the brain to within several microns of the target area, without causing damage to surrounding neurons.
Currently, brain implants often require complex and costly surgical procedures, potentially exceeding hundreds of thousands of dollars. Circulatronics offers a potentially transformative solution. “This technology holds the potential to make therapeutic brain implants accessible to all by eliminating the need for surgery,” stated Deblina Sarkar, the AT&T Career Growth Associate Professor in the MIT Media lab and MI
The sarkar lab is currently expanding the request of this technology to treat a range of debilitating conditions, including brain cancer, alzheimer’s disease, and chronic pain. The unique capabilities of circulatronics could be particularly beneficial in treating brain cancers like glioblastoma, which often presents with multiple, small tumors that are difficult to detect with conventional imaging. It also offers potential for treating aggressive tumors like diffuse intrinsic pontine glioma, which are often inoperable.
“This is a platform technology and may be employed to treat multiple brain diseases and mental illnesses,” Sarkar emphasized. “Also, this technology is not just confined to the brain but could also be extended to other parts of the body in future.”
The researchers are optimistic about transitioning the technology into clinical trials within the next three years through their newly launched startup, Cahira Technologies. They are also exploring the integration of additional nanoelectronic circuits to enhance device functionality, including sensing capabilities, on-chip data analysis, and the creation of synthetic electronic neurons.
“Our tiny electronic devices seamlessly integrate with the neurons and co-live and co-exist with the brain cells, creating a unique brain-computer symbiosis,” Sarkar concluded. “We are working dedicatedly to employ this technology for treating neural diseases, where drugs or standard therapies fail, for alleviating human suffering and envision a future where humans could transcend beyond diseases and biological limitations.”
More details: A nonsurgical brain implant enabled through a cell-electronics hybrid for focal neuromodulation, Nature Biotechnology (2025). DOI: 10.1038/s41587-025-02809-3.
provided by Massachusetts Institute of Technology.
